Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

Similar documents
Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report

12/1/2017. Disclosures. Objectives. The Microbiome Defined

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Corporate Medical Policy Fecal Microbiota Transplantation

Microbiome GI Disorders

Dysbiosis & Inflammation

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

Faecalibacterium prausnitzii

Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's Disease

Fecal transplantation as a treatment option for recurrent Clostridium difficile infection

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

Role of the Gut Microbiota in Autoimmunity

Clinical Review Criteria Fecal Microbial Transplant for Treatment of C. Difficile Infection Fecal GI Infusion Fecal Capsule (G3 OpenBiome)

HOW THE MICROBIOME AFFECTS OUR HEALTH

MICROBIOMA E IMMUNITA LORENZO EMMI

Functional Nutrition Approaches to Gut Health 20 CPEU Module accredited by Nutrition Mission

Fecal Microbiota Transplantation

more intense treatments are needed to get rid of the infection.

Consistent and Reproducible Production of a Microbiota-based Drug for Recurrent C. difficile

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

Star Articles in Review

Probiotics for Primary Prevention of Clostridium difficile Infection

Antibiotic Resistance and Probiotics - A Metagenomic Viewpoint

Clinical Policy Bulletin: Fecal Bacteriotherapy

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

THE ROLE OF MICROBIOME IN IBD

9/18/2018. The Physiological Roles of the Intestinal Microbiota. Learning Objectives

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

C. difficile: When to Do Fecal Microbiota Transplant (FMT)

Beyond the Scope: The Microbiome & The Future of Gastroenterology

Bibliografia Microbiota

The Intestinal Microbiota and the Developing Immune System

Fecal Microbiota Transplantation in C. diff. colitis Benefits and Limitations

Fecal Microbiota Transplantation. Description

general meeting 1 20 October 2016

Gut Microbiota Transplant Pro Position. Christina Surawicz, MD, MACG Professor of Medicine University of Washington Seattle WA

Beyond the Scope: An Integrative Gastroenterologist s Approach to Digestive Disorders

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know

Intestinal Microbiota in Health and Disease

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy

Duodenal infusion of donor feces for recurrent Clostridium difficile infection A French experience

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

All POOPed out: fecal microbiota transplant in C. difficile

Gut bugs and health. Patrick Bateson

The GI Microbiome and its role in Chronic Fatigue Syndrome: a Summary of Bacteriotherapy

Pennington Feb 19, 2015

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

Clinical Policy Title: Fecal transplantation for the treatment of clostridium difficile infection

Fecal microbial transplantation

INTRODUCING YOUR GUT BACTERIA

The human microbiome and how it affects heath. Nafisa M. Jadavji, PhD

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

Sarkis K Mazmanian, California Institute of Technology

Fecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein

Original Article YH FANG, J CHEN, JD YU, YY LUO, JG LOU. Key words. Introduction

Stool Testing for the Microbiome - Ready for Primetime?

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook

The impact of the microbiome on brain and cognitive development

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota

Patient Safety Summit 2014

Title: Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease

Fecal Microbiota Transplantation: Clinical and experimental studies van Nood, E.

Understanding probiotics and health

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

2/13/2018. What s bugging you? Relevance of the Human Microbiome in Health and Disease Heidi H. Kong, MD, MHSc, FAAD Dermatology Branch

Breastfeeding and the Microbiome

Mark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions

DISCUSSION GROUP #5 ISAPP 2014 THE MICROBIOME AND HEALTH: PROMISING ENDPOINTS FOR INTERVENTIONS. Friday, June 20, 2014

Module Four: The GI System Module Five: The Gut Microbiome. The GI System. LLiana Shanti, CN

Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study

Corporate Medical Policy

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

The effect of probiotics on animal health: a focus on host s natural intestinal defenses

FECAL TRANSPLANTATION

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Probiotics in IBS. Dr. Partha Pratim Das Associate Professor Dhaka Medical college

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town

Figure S1, SDC Additional measures of microbial diversity during perioperative period In addition to the Shannon diversity index of Figure 1,

A STUDY INTO THE HUMAN GUT MICROBIOME A RESEARCH PAPER SUBMITTED TO THE GRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIREMENTS

HUMAN GUT MICROBIOTA

The role of nutrition in optimum gastrointestinal health

PROBIONA. PROBIOTICS with 5 bacterial strains. Suitable during and after the use of antibiotics to restore intestinal microflora.

Clinical Infectious Diseases Advance Access published December 7, 2012

XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos

SIBO

SUPPLEMENTARY INFORMATION

Drugs for Bugs: The Next Generation of Pharmaceuticals

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Natural and Holistic Medicine Approach in Evaluation and Treatment of Vaginal and Urinary Tract Health

Natural defense of the gastrointestinal tract

The vital role of the microbiome in human health

!Microbiology Profile, stool

Necrotizing Enterocolitis: The Role of the Immune System

The role of gut microbiome in IBS

Transcription:

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report Qiurong Li Institute of General Surgery, Jinling Hospital Nanjing Univeristy

Gut Microbiota 100 trillion cells 10-fold of the human cell number > 200 genera, >500 microbial species gastrointestinal tract harbors >80% of total microbes in human body is a major component of intestinal barrier

Vital Roles of Gut Microbiota Gut microbiota is recently considered as an important organ carries out vital processes for human physiology and nutrition the microbiota dysbiosis is closely involved in infection, colitis, and metabolic disorders

Sepsis and Intestinal Dysbiosis As shown in the right image, in the healthy gut, commensal microbiota suppresses the proliferation and colonization of enteric pathogens. conversely, the disruption of gut microbial community could allow enteric bacteria to translocate the circulation, leading to systemic infection and septic shock. The dysbiosis of gut microbiota are often seen in sepsis patients. Therefore, dysbiosis of gut microbiota is probably relevant for the etiology of sepsis. Cited from: Nature Immuno. 2013; 14: 685-690.

Therapeutic Value of Microbiota-targeted Modulation Recent studies have showed: modulation of gut microbiota can promote the eradication of enteric pathogens, such as Clostridium difficile, EPEC and EHEC the gut microbiota can enhance mucosal immunity to defend against enteric infection providing an interesting possibility of harnessing the gut microbiota Interventions to clearing bacterial pathogens and to restore host immune balance in sepsis

Fecal Microbiota Transplantation (FMT) also named as fecal transplant, fecal bacteriotherapy used primarily to treat Clostridium Difficileassociated infection (CDI) and IBD its cure rate is up to 90% in CDI the mechanism underlying the procedure is to correct the intestinal dysbiosis by introducing donor-fecal microbiota indicating it s potential in treatment of other microbiota-associated diseases, such as sepsis.

Case Presentation The patient: a 44-year old woman hospitalized for gastric aches was then diagnosed with gastric neuroendocrine tumor underwent a proximal gastrectomy and bilateral truncal vagotomy at April, 2013 The operation was successful, and no surgical complication

Onset of Septic shock The postoperative course was uneventful until the 4th day, when the blood pressure suddenly decreased (60/38 mm Hg) the heart and breath rates were increased acute respiratory distress presented (blood oxygen saturation 86%) Subsequently, the temperature was high fever (39.6ºC ) watery diarrhea was developed Laboratory examinations showed 1d 2 d 3d 4d 5d 6d the white-cell count was reduced (2.9 10 9 /L ) blood lactate level: 8.2 mmol/l serum C-reactive protein (CRP): 143.4 mg/l Septic shock was considered 39 38 37 Surgery day

Interventions The treatment mainly included: supportive strategies trachea intubated vasopressor drugs corticosteroids intensive intravenous fluids ECMO and CRRT (6 days) antibiotic administration multiple antibiotics were intravenously given probiotic supplement

After treated for about 1 month, Outcomes the patient s vital symptoms became stabilized Unfortunately, the fevers were remained (38.3ºC) watery diarrhea was persistent and didn t improve (>2000mL/d) In addition, blood cultures were continuously positive elevated inflammatory mediators, including TNF-α, IL-1β, IL-6, IL-10, IL-18, IFN-γ,HMGB-1 dysregulation of innate immune cells, especially imbalance of Th cells (Th1/2/17) It is required to search for novel therapeutic strategies to restore immune balance and clear the inflammatory response.

Assessment of Gut Microbiota Considering the possibility of intestinal dysbiosis, we evaluated the fecal microbiota in the patient. Phylum We showed that the patient s microbiota was extensively perturbed, characterized by very low similarity (<10%) comparing to Family the healthy control biodiversity also decreased significant depletion in the commensal organisms of Firmicutes and Bacteroidetes Species overgrowth of the pathobionts in Proteobacteria, especially Enterobacter cloacae, Yersinia enterocolitica, Raoultella ornithinolytica

Our Hypothesis Based on the data above, we speculated that correction of the microbiota dysbiosis is probably a vital step for the treatment of the patient fecal transplantation may be an ideal therapeutic option especially for the extensive disturbance Expectation to the next step Development of the disease

Donor: Infusion of Donor-feces the patient s brother screened to exclude bloodborne communicable diseases validated negative for common stool pathogens Transfer of fecal suspension: 70 grams of donor feces freshly collected was used to make a slurry the slurry was then filtered to remove particulate matter 120 ml of the filtrates were infused via the nasogastric tube

Clinical Improvement After infusion of donor-feces, the fevers went down in the next day there was no recurrence in septic symptoms in the following days more importantly, cultures of the blood became sterile. FMT 38 37

Within the 4 days, The Second FMT no significant improvement in watery diarrhea was seen Thereby, we conducted the second FMT on the 4th day Subsequently, the frequency and output of stools began to reduce diarrhea was completely controlled at 17 days The second FMT FMT

Response of Th cells to FMT Following the FMT, Th-cell population (Th 1, Th2, Th17) shifted towards normal composition the balance of the innate immune cells restored 7 days later indicated that FMT may feedback to influence host immunity

Alleviation of Systemic Inflammatory Response Interestingly, Serum levels of multiple cytokines, including IL-1, IL-6, TNF-α and IFN-γ, decreased to be normalized after 12 days. the excessive inflammatory response was well controlled

Modification of Gut Microbiota following FMT In attempt to explore the mechanism underlying the clinical improvements, we further evaluated the shifts of the fecal microbiota composition after the treatment. The structure of intestinal microbiota significantly changed, especially 6 days later The community structures trended to be stable after 14 days The structure similarities increased to 40-50% compared to the donor Principal component analysis also supported the results

Compositional Changes of Gut microbiota The microbiota composition shifted towards normalized following FMT The most significant shifts in the microbiota were a profound expansion in Firmicutes and a striking reduction in Proteobacteria the commensal organisms, including Lactobacillus plantarum, Eubacterium eligens and Veillonella dispar, largely colonized and dominated in the microbiotas. the pathobionts of the family Enterobacteriaceae, were significantly depleted. FMT may induce a significant modification in gut microbiota, reshaping a microecologically defense barrier in the patient. Phylum Family Species

Phylogenetic Analysis It provided further evidence indicating the shifts in microbial composition.

Associations between Clinical Benefits and Gut Microbiota The Firmicutes and the families Streptococcaceae, Lactobacillaceae were negatively correlated with inflammatory markers, such as IL-6, IL-18, HMGB-1, or CRP, or Th 2 cell. The Proteobacteria and Enterobacteriaceae were positively correlated with them. indicated that the clinical improvements may be attributed to the modulation of the microbiotas.

Alterations of Gut Microbiota and Diarrhea Correlative analyses also suggested a close link between gut microbiota changes and stool output. The taxon abundance of Firmicutes and Streptococcaceae was negatively associated with the output of stools. The Proteobacteria and Enterobacteriaceae positively correlated with it. As a result, effective control of watery diarrhea might benefit from reconstruction of the gut microbiota by FMT.

Conclusions On the basis of the data, we demonstrate: FMT is probably effective in treating sepsis and severe diarrhea. The clinical benefits from the unconventional approach is, at least in part, due to FMT being able to facilitate the reestablishment of normal microbiota. FMT might also elicit immunological mechanism to restore intestinal homeostasis and protect the patient. Lastly, but the most important, is that, FMT may provide an ideal therapeutic alternative for sepsis, which might be especially suitable for the patients without improvement from conventional strategies.

Questions? Thanks a lot